NeuroOne Medical Technologies Corporation Deferred Revenue
NeuroOne Medical Technologies Corporation (NMTC) had Deferred Revenue of $1.46 million as of 2022-09-30, per its 10-K filed 2023-12-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2023-12-15
- 2022-09-30: Deferred Revenue, Current $1.46M.
- 2022-06-30: Deferred Revenue, Current $2.25K.
- 2021-09-30: Deferred Revenue, Current $8.62K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2022-09-30 | $1.46M 10-K · filed 2023-12-15 |
| 2022-06-30 | $2.25K 10-Q · filed 2023-08-14 |
| 2021-09-30 | $8.62K 10-K · filed 2023-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |